Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMAB008 vs Remicade in Rheumatoid Arthritis
NCT03478111Phase 3Completed
- Sponsor
- Shanghai Biomabs Pharmaceuticals
- Start
- Mar 2018
- Primary completion
- Jun 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab-axxq in rheumatoid arthritis (RA), sponsored by Shanghai Biomabs Pharmaceuticals. Started Mar 2018; status: completed.
02
Drugs
infliximab-axxq
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03478111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03478111.